Chemical Instability in Peptide and Protein Pharmaceuticals

[1]  H. Scheraga,et al.  Disulfide bonds and protein folding. , 2000, Biochemistry.

[2]  D. Volkin,et al.  Degradative covalent reactions important to protein stability. , 1997, Methods in molecular biology.

[3]  Ronald T Borchardt,et al.  Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. , 2006, Journal of pharmaceutical sciences.

[4]  Bernard R Brooks,et al.  A comprehensive picture of non-site specific oxidation of methionine residues by peroxides in protein pharmaceuticals. , 2004, Journal of pharmaceutical sciences.

[5]  C. Jones,et al.  Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. , 1996, Vaccine.

[6]  B. Freeman,et al.  Sulfenic acid in human serum albumin , 2006, Amino Acids.

[7]  A. Klibanov,et al.  Thermal destruction processes in proteins involving cystine residues. , 1987, The Journal of biological chemistry.

[8]  Hongcheng Liu,et al.  Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Michael J Harms,et al.  Laser light‐scattering evidence for an altered association of βB1‐crystallin deamidated in the connecting peptide , 2004, Protein science : a publication of the Protein Society.

[10]  Bernhardt L. Trout,et al.  Effects of Antioxidants on the Hydrogen Peroxide-Mediated Oxidation of Methionine Residues in Granulocyte Colony-Stimulating Factor and Human Parathyroid Hormone Fragment 13-34 , 2004, Pharmaceutical Research.

[11]  L. B. Larsen,et al.  Changes in structures of milk proteins upon photo-oxidation. , 2007, Journal of agricultural and food chemistry.

[12]  R. Beynon,et al.  Asparagine deamidation and the role of higher order protein structure. , 2008, Journal of proteome research.

[13]  A. Lim,et al.  Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. , 2007, Mass spectrometry reviews.

[14]  K. Gates,et al.  Generation of reactive oxygen species by a persulfide (BnSSH). , 2005, Bioorganic & medicinal chemistry letters.

[15]  L. Kirsch,et al.  The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions. , 2002, Journal of pharmaceutical sciences.

[16]  Y. Sadakane,et al.  Differential rate constants of racemization of aspartyl and asparaginyl residues in human alpha A-crystallin mutants. , 2008, Biochimica et biophysica acta.

[17]  Hongcheng Liu,et al.  Fragmentation of a Recombinant Monoclonal Antibody at Various pH , 2008, Pharmaceutical Research.

[18]  C. Hsu,et al.  Influence of calcium ions on the structure and stability of recombinant human deoxyribonuclease I in the aqueous and lyophilized states. , 1999, Journal of pharmaceutical sciences.

[19]  L. Mazzarella,et al.  Solvent effects on diketopiperazine formation from N-terminal peptide residues , 1999 .

[20]  E. Stadtman,et al.  Oxidative modification of Escherichia coli glutamine synthetase. Decreases in the thermodynamic stability of protein structure and specific changes in the active site conformation. , 1992, The Journal of biological chemistry.

[21]  C. Schöneich,et al.  Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. , 2001, Journal of pharmaceutical sciences.

[22]  Maria Cristina Gaudiano,et al.  Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes. , 2005, Biochimica et biophysica acta.

[23]  Y. Koo,et al.  Stabilization method of an alkaline protease from inactivation by heat, SDS and hydrogen peroxide , 2005 .

[24]  D. Chelius,et al.  Accumulation of Succinimide in a Recombinant Monoclonal Antibody in Mildly Acidic Buffers Under Elevated Temperatures , 2007, Pharmaceutical Research.

[25]  N. Sepetov,et al.  Spontaneous chemical degradation of substance P in the solid phase and in solution. , 2009, International journal of peptide and protein research.

[26]  B. Freeman,et al.  Reactivity of sulfenic acid in human serum albumin. , 2008, Biochemistry.

[27]  B. Cunningham,et al.  Dimerization of human growth hormone by zinc. , 1991, Science.

[28]  B. V. Fisher,et al.  Stability of bovine insulin , 1981, The Journal of pharmacy and pharmacology.

[29]  D. Raleigh,et al.  Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides : Implications for the study of amyloid formation , 2000 .

[30]  V. Uversky,et al.  Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro , 2002 .

[31]  R T Borchardt,et al.  Inhibitory effect of sugars and polyols on the metal-catalyzed oxidation of human relaxin. , 1996, Journal of pharmaceutical sciences.

[32]  R Tyler-Cross,et al.  Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. , 1991, The Journal of biological chemistry.

[33]  W. Hancock,et al.  Glycation of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation. Part III: application of proteomic analysis to the manufacture of biological drugs. , 2006, International journal of pharmaceutics.

[34]  Bruce A Kerwin,et al.  Protect from light: photodegradation and protein biologics. , 2007, Journal of pharmaceutical sciences.

[35]  M. Mulkerrin,et al.  Influence of Histidine on the Stability and Physical Properties of a Fully Human Antibody in Aqueous and Solid Forms , 2003, Pharmaceutical Research.

[36]  Wei Wang,et al.  Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.

[37]  E. Ajandouz,et al.  Nonenzymatic browning reaction of essential amino acids: effect of pH on caramelization and Maillard reaction kinetics. , 1999, Journal of agricultural and food chemistry.

[38]  A. Vizel’,et al.  Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development. , 2006, Journal of pharmaceutical and biomedical analysis.

[39]  E. Stadtman,et al.  Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.

[40]  P. Gallop,et al.  Covalent protein crosslinks: general detection, quantitation, and characterization via modification with diphenylborinic acid. , 1994, Analytical biochemistry.

[41]  G. Monard,et al.  Computational study on nonenzymatic peptide bond cleavage at asparagine and aspartic acid. , 2008, The journal of physical chemistry. A.

[42]  A. Klibanov,et al.  Deterioration of lyophilized pharmaceutical proteins. , 1998, Biochemistry. Biokhimiia.

[43]  W. Hancock,et al.  Diketopiperazine formation and N-terminal degradation in recombinant human growth hormone. , 2009, International journal of peptide and protein research.

[44]  W. Hancock,et al.  Characterization of humanized anti-TAC, an antibody directed against the interleukin 2 receptor, using electrospray ionization mass spectrometry by direct infusion, LC/MS, and MS/MS. , 1994, Analytical chemistry.

[45]  C. Schebor,et al.  Color formation due to non-enzymatic browning in amorphous, glassy anhydrous model systems , 1999 .

[46]  J. Gerrard.  New Aspects of an AGEing Chemistry— Recent Developments Concerning the Maillard Reaction , 2002 .

[47]  B. Blombäck.  [44] Derivatives of glutamine in peptides☆ , 1967 .

[48]  Catherine D. Kim,et al.  Determination of the origin of the N‐terminal pyro‐glutamate variation in monoclonal antibodies using model peptides , 2007, Biotechnology and bioengineering.

[49]  J. King,et al.  Glutamine Deamidation Destabilizes Human γD-Crystallin and Lowers the Kinetic Barrier to Unfolding* , 2006, Journal of Biological Chemistry.

[50]  C. Schöneich,et al.  Solid-state photodegradation of bovine somatotropin (bovine growth hormone): evidence for tryptophan-mediated photooxidation of disulfide bonds. , 2003, Journal of pharmaceutical sciences.

[51]  Charles L. Cooney,et al.  Relationship between Protein Structure and Methionine Oxidation in Recombinant Human α1-Antitrypsin , 2002 .

[52]  John M. Lambert,et al.  Structural Characterization of a Recombinant Monoclonal Antibody by Electrospray Time-of-Flight Mass Spectrometry , 2005, Pharmaceutical Research.

[53]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[54]  S. Foley,et al.  Reductive unfolding of serum albumins uncovered by Raman spectroscopy. , 2008, Biopolymers.

[55]  Ronald T Borchardt,et al.  Asparagine deamidation in recombinant human lymphotoxin: hindrance by three-dimensional structures. , 2003, Journal of pharmaceutical sciences.

[56]  Douglas S Rehder,et al.  Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. , 2006, Journal of chromatography. A.

[57]  T. Creighton,et al.  Effect of protein conformation on rate of deamidation: Ribonuclease A , 1989, Proteins.

[58]  T. H. Nguyen,et al.  Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. , 1995, Biochemistry.

[59]  A. Gaertner,et al.  The excluding effects of sucrose on a protein chemical degradation pathway: methionine oxidation in subtilisin. , 2000, Archives of biochemistry and biophysics.

[60]  V. Uversky,et al.  Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN. , 2008, Biochemistry.

[61]  G Shimamoto,et al.  Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity. , 1999, Archives of biochemistry and biophysics.

[62]  A. Grillo,et al.  Conformational origin of the aggregation of recombinant human factor VIII. , 2001, Biochemistry.

[63]  Michael J. Pikal,et al.  Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.

[64]  R T Borchardt,et al.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. , 1995, Biotechnology and bioengineering.

[65]  Rahul S Rajan,et al.  Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. , 2006, Analytical chemistry.

[66]  M. Manning,et al.  Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor. , 2000, Journal of pharmaceutical sciences.

[67]  J. Ames,et al.  Site specificity of glycation and carboxymethylation of bovine serum albumin by fructose , 2006, Amino Acids.

[68]  E. Stadtman,et al.  Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.

[69]  B. Thomas,et al.  N5-Methylasparagine and asparagine as nucleophiles in peptides : main-chain vs side-chain amide cleavage , 1993 .

[70]  R. Borchardt,et al.  Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. , 2000, Biochemistry.

[71]  M. Otagiri,et al.  The role of N-acetyl-methioninate as a new stabilizer for albumin products. , 2007, International journal of pharmaceutics.

[72]  L. Mazzarella,et al.  Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline-3-carboxylic acid at position 2. , 2009, International journal of peptide and protein research.

[73]  J. Hong,et al.  The metal-catalyzed oxidation of methionine in peptides by Fenton systems involves two consecutive one-electron oxidation processes. , 2001, Free radical biology & medicine.

[74]  M. Steinmetz,et al.  Design of a Coiled-Coil-based Model Peptide System to Explore the Fundamentals of Amyloid Fibril Formation , 2005, International Journal of Peptide Research and Therapeutics.

[75]  N. Sepetov,et al.  Rearrangement, racemization and decomposition of peptides in aqueous solution. , 1991, Peptide research.

[76]  A. Kossiakoff,et al.  Tertiary structure is a principal determinant to protein deamidation. , 1988, Science.

[77]  C. Schöneich.  Mechanisms of protein damage induced by cysteine thiyl radical formation. , 2008, Chemical research in toxicology.

[78]  V. Smrečki,et al.  Fructose‐induced N‐terminal glycation of enkephalins and related peptides , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[79]  Yutaka Sadakane,et al.  Kinetic study of racemization of aspartyl residues in recombinant human alphaA-crystallin. , 2006, Biochimica et biophysica acta.

[80]  C. Schöneich,et al.  Loss of conformational stability in calmodulin upon methionine oxidation. , 1998, Biophysical journal.

[81]  S. Clarke,et al.  Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.

[82]  S. Dharmsthiti,et al.  Effect of glycation on stability and kinetic parameters of thermostable glucoamylase from Aspergillus niger , 2005 .

[83]  H. Friesen,et al.  Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. , 1987, The Journal of biological chemistry.

[84]  A. Klibanov,et al.  Solid-phase aggregation of proteins under pharmaceutically relevant conditions. , 1994, Journal of pharmaceutical sciences.

[85]  M. Messer.  Enzymatic Cyclization of L-Glutamine and L-Glutaminyl Peptides , 1963, Nature.

[86]  L. Mazzarella,et al.  Mechanism of 2,5-Dioxopiperazine Formation , 1998 .

[87]  Daniel I. C. Wang,et al.  Effects of Excipients on the Hydrogen Peroxide-Induced Oxidation of Methionine Residues in Granulocyte Colony-Stimulating Factor , 2004, Pharmaceutical Research.

[88]  I. Apostol,et al.  Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications. , 1999, Journal of pharmaceutical sciences.

[89]  J. Hong,et al.  Metal-catalyzed oxidation of human growth hormone: modulation by solvent-induced changes of protein conformation. , 2001, Journal of pharmaceutical sciences.

[90]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[91]  F. LaBella,et al.  Fluorescent substances in protein hydrolyzates. I. Acid "hydrolyzates" of individual amino acids. , 1970, Analytical Biochemistry.

[92]  Š. Horvat,et al.  Transformations of bioactive peptides in the presence of sugars--characterization and stability studies of the adducts generated via the Maillard reaction. , 2006, Bioorganic & medicinal chemistry.

[93]  W. Busby,et al.  An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. , 1987, The Journal of biological chemistry.

[94]  Š. Horvat,et al.  Peptide and amino acid glycation: new insights into the Maillard reaction , 2004, Journal of peptide science : an official publication of the European Peptide Society.

[95]  J. Bunnett.  The Mechanism of Bimolecular β‐Elimination Reactions , 1962 .

[96]  P. Schiller,et al.  Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence. , 2009, International journal of peptide and protein research.

[97]  R. Borchardt,et al.  Reactivity toward deamidation of asparagine residues in beta-turn structures. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[98]  K. Harada,et al.  Simultaneous racemization and isomerization at specific aspartic acid residues in alpha B-crystallin from the aged human lens. , 1994, Biochimica et biophysica acta.

[99]  T. Shibanuma,et al.  Reversed phase HPLC of Met58 oxidized rhIL-11: oxidation enhanced by plastic tubes. , 2000, Journal of pharmaceutical and biomedical analysis.

[100]  M. Davies,et al.  Photodynamically generated bovine serum albumin radicals: evidence for damage transfer and oxidation at cysteine and tryptophan residues. , 1998, Free radical biology & medicine.

[101]  K. Kawai,et al.  The rate of non-enzymatic browning reaction in model freeze–dried food system in the glassy state , 2005 .

[102]  D. Brems,et al.  Oxidation of methionine residues in recombinant human interleukin-1 receptor antagonist: implications of conformational stability on protein oxidation kinetics. , 2007, Biochemistry.

[103]  J. Hong,et al.  Metal-catalyzed Oxidation of Histidine in Human Growth Hormone , 1997, The Journal of Biological Chemistry.

[104]  D. M. Kennedy,et al.  Glycation of monoclonal antibodies impairs their ability to bind antigen , 1994, Clinical and experimental immunology.

[105]  A. Hawe,et al.  Development of HSA-free formulations for a hydrophobic cytokine with improved stability. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[106]  Hongcheng Liu,et al.  Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[107]  C. Schöneich,et al.  Characterization of the metal-binding site of bovine growth hormone through site-specific metal-catalyzed oxidation and high-performance liquid chromatography-tandem mass spectrometry. , 2002, Analytical biochemistry.

[108]  T. Shirasawa,et al.  Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. , 1994, The Journal of biological chemistry.

[109]  B. D. Anderson,et al.  The role of the cyclic imide in alternate degradation pathways for asparagine-containing peptides and proteins. , 2007, Journal of pharmaceutical sciences.

[110]  J. Cleland,et al.  Comparison Between Light Induced and Chemically Induced Oxidation of rhVEGF , 2001, Pharmaceutical Research.

[111]  M C Manning,et al.  Controlling deamidation rates in a model peptide: effects of temperature, peptide concentration, and additives. , 2001, Journal of pharmaceutical sciences.

[112]  A. Rosenberg,et al.  A risk-based approach to immunogenicity concerns of therapeutic protein products: Part 2. Considering host-specific and product-specific factors impacting immunogenicity , 2004 .

[113]  Jack Y. Zheng,et al.  Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298. , 2006, International journal of pharmaceutics.

[114]  C. Foote,et al.  CHEMISTRY OF SINGLET OXYGEN—XXV. PHOTOOXYGENATION OF METHIONINE * , 1977 .

[115]  C. Smales,et al.  Protein Modifications during Antiviral Heat Bioprocessing and Subsequent Storage , 2001, Biotechnology progress.

[116]  T. Calderwood,et al.  Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor. , 1996, PDA journal of pharmaceutical science and technology.

[117]  Ziping Wei,et al.  Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. , 2007, Analytical chemistry.

[118]  P. D. de Groot,et al.  Glycation Induces Formation of Amyloid Cross-β Structure in Albumin* , 2003, Journal of Biological Chemistry.

[119]  S. Capasso,et al.  Kinetic and thermodynamic control of the relative yield of the deamidation of asparagine and isomerization of aspartic acid residues. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[120]  Hendrik Zipse,et al.  ACCELERATED RACEMIZATION OF ASPARTIC ACID AND ASPARAGINE RESIDUES VIA SUCCINIMIDE INTERMEDIATES : AN AB INITIO THEORETICAL EXPLORATION OF MECHANISM , 1996 .

[121]  David VanderVelde,et al.  Racemization of an asparagine residue during peptide deamidation. , 2003, Journal of the American Chemical Society.

[122]  Tung-Ching Lee,et al.  KINETICS and MECHANISM of NONENZYMATIC DEAMIDATION of SOY PROTEIN , 1993 .

[123]  D. Craik,et al.  Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? , 1998, Biochemistry.

[124]  M. Davies,et al.  Generation and propagation of radical reactions on proteins. , 2001, Biochimica et biophysica acta.

[125]  S. Frokjaer,et al.  Effects of sucrose on rFVIIa aggregation and methionine oxidation. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[126]  R. Vachet,et al.  Metal-catalyzed oxidation reactions and mass spectrometry: the roles of ascorbate and different oxidizing agents in determining Cu-protein-binding sites. , 2005, Analytical biochemistry.

[127]  W. Jiskoot,et al.  Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[128]  Da Ren,et al.  Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. , 2008, Biochemistry.

[129]  R. Truscott,et al.  Photo-oxidation of proteins and its role in cataractogenesis. , 2001, Journal of photochemistry and photobiology. B, Biology.

[130]  Steven L. Cohen,et al.  Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. , 2007, Journal of the American Chemical Society.

[131]  K. Schey,et al.  Identification of peptide oxidation by tandem mass spectrometry. , 2000, Accounts of chemical research.

[132]  Margaret Ricci,et al.  The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. , 2007, Journal of pharmaceutical sciences.

[133]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[134]  Alain Balland,et al.  Characterization of nonenzymatic glycation on a monoclonal antibody. , 2007, Analytical chemistry.

[135]  E. Schleicher,et al.  New Aspects of the Maillard Reaction in Foods and in the Human Body , 1990 .

[136]  J L Cleland,et al.  Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. , 1997, Journal of pharmaceutical sciences.

[137]  D. Urry,et al.  Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. , 1991, Critical reviews in biochemistry and molecular biology.

[138]  Diketopiperazines in peptide and combinatorial chemistry , 2003, Journal of peptide science : an official publication of the European Peptide Society.

[139]  Bernhardt L Trout,et al.  Molecular dynamics simulations and oxidation rates of methionine residues of granulocyte colony-stimulating factor at different pH values. , 2004, Biochemistry.

[140]  John M Lambert,et al.  Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometry , 2005, Protein science : a publication of the Protein Society.

[141]  M. Otagiri,et al.  Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress. , 2004, Biochimica et biophysica acta.

[142]  C. Schöneich,et al.  Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins. , 2000, Journal of pharmaceutical and biomedical analysis.

[143]  E. Topp,et al.  Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.

[144]  A. R. Friedman,et al.  Solution conformation of Leu27 hGRF(1-32)NH2 and its deamidation products by 2D NMR. , 2009, International journal of peptide and protein research.

[145]  L. Lorand,et al.  Lens transglutaminase and cataract formation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[146]  D. Aswad,et al.  Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? , 2003, Cellular and Molecular Life Sciences CMLS.

[147]  E Persson,et al.  Oxidation of methionine residues in coagulation factor VIIa. , 1999, Archives of biochemistry and biophysics.

[148]  T. Shirasawa,et al.  Isomerization and/or racemization at Asp23 of Abeta42 do not increase its aggregative ability, neurotoxicity, and radical productivity in vitro. , 2008, Biochemical and biophysical research communications.

[149]  A. S. Inglis.  [28] Cleavage at aspartic acid , 1983 .

[150]  L. Grossweiner.  Photochemistry of proteins: a review. , 1984, Current eye research.

[151]  G. Buettner,et al.  Catalytic metals, ascorbate and free radicals: combinations to avoid. , 1996, Radiation research.

[152]  K. Sakai-Kato,et al.  Racemization of the amyloidal beta Asp1 residue blocks the acceleration of fibril formation caused by racemization of the Asp23 residue. , 2007, Biochemical and biophysical research communications.

[153]  J. Ramshaw,et al.  Effect of deamidation on stability for the collagen to gelatin transition. , 2005, Journal of Agricultural and Food Chemistry.

[154]  L. Bell,et al.  Glycine Loss and Maillard Browning as Related to the Glass Transition in a Model Food System , 2006 .

[155]  Lee E Kirsch,et al.  The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon. , 2004, International journal of pharmaceutics.

[156]  J. Brange.  Chemical stability of insulin. 4. Mechanisms and kinetics of chemical transformations in pharmaceutical formulation. , 1992, Acta pharmaceutica Nordica.

[157]  Kent Axelsson,et al.  Oxidation of Human Insulin-like Growth Factor I in Formulation Studies: Kinetics of Methionine Oxidation in Aqueous Solution and in Solid State , 1996, Pharmaceutical Research.

[158]  T. H. Nguyen,et al.  Oxidation Degradation of Protein Pharmaceuticals. , 1995 .

[159]  L. Bell,et al.  Maillard reaction in glassy low-moisture solids as affected by buffer type and concentration , 1998 .

[160]  Viktorya Aviyente,et al.  Reaction mechanism of deamidation of asparaginyl residues in peptides: effect of solvent molecules. , 2006, The journal of physical chemistry. A.

[161]  S. Capasso,et al.  Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[162]  Magnus Palmblad,et al.  Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers* , 2002, The Journal of Biological Chemistry.

[163]  P. Armentrout,et al.  Thermodynamics and mechanism of the deamidation of sodium-bound asparagine. , 2008, Journal of the American Chemical Society.

[164]  Theodore W Randolph,et al.  Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. , 2003, Biochemistry.

[165]  G. Lajoie,et al.  Modification of tryptophan and methionine residues is implicated in the oxidative inactivation of surfactant protein B. , 2007, Biochemistry.